{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T23:54:56Z","timestamp":1782258896997,"version":"3.54.5"},"reference-count":26,"publisher":"Elsevier BV","issue":"2-3","license":[{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy Research"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1016\/j.eplepsyres.2011.07.020","type":"journal-article","created":{"date-parts":[[2011,12,21]],"date-time":"2011-12-21T20:35:06Z","timestamp":1324499706000},"page":"247-250","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Olanzapine-associated myoclonus"],"prefix":"10.1016","volume":"98","author":[{"given":"Jennifer Block","family":"Rosen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark J.","family":"Milstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheryl R.","family":"Haut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eplepsyres.2011.07.020_bib0005","first-page":"S68","article-title":"Seizure risk associated with psychotropic drugs: clinical and pharmacokinetic considerations","volume":"53","author":"Alldredge","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.eplepsyres.2011.07.020_bib0010","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/hup.537","article-title":"EEG abnormalities associated with antipsychotics: a comparison of quetiapine, olanzapine, haloperidol and healthy subjects","volume":"18","author":"Amann","year":"2003","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.eplepsyres.2011.07.020_bib0015","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.1528-1157.2000.tb00192.x","article-title":"Myoclonus associated with the use of gabapentin","volume":"41","author":"Asconap\u00e9","year":"2000","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2011.07.020_bib0020","first-page":"219","article-title":"Myoclonus in patients treated with clozapine: a case series","volume":"58","author":"Bak","year":"1997","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.eplepsyres.2011.07.020_bib0025","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1345\/aph.1C288","article-title":"Olanzapine-associated seizure","volume":"37","author":"Bonelli","year":"2003","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.eplepsyres.2011.07.020_bib0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clineuro.2004.07.012","article-title":"Neurologic complications in renal failure: a review","volume":"107","author":"Brouns","year":"2004","journal-title":"Clin. Neurol. Neurosurg."},{"key":"10.1016\/j.eplepsyres.2011.07.020_bib0035","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/01.wnf.0000165351.10841.fa","article-title":"Olanzapine-induced myoclonic status","volume":"28","author":"Camacho","year":"2005","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.eplepsyres.2011.07.020_bib0040","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1136\/jnnp.42.1.52","article-title":"Uraemic myoclonus: an example of reticular reflex myoclonus","volume":"42","author":"Chadwick","year":"1979","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.eplepsyres.2011.07.020_bib0045","doi-asserted-by":"crossref","first-page":"237","DOI":"10.3340\/jkns.2008.43.5.237","article-title":"Myoclonus induced by the use of gabapentin","volume":"43","author":"Cho","year":"2008","journal-title":"J. Korean Neurosurg. Soc."},{"key":"10.1016\/j.eplepsyres.2011.07.020_bib0050","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1097\/00004714-200004000-00034","article-title":"Seizures caused by possible interaction between olanzapine and clomipramine","volume":"20","author":"Deshauer","year":"2000","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.eplepsyres.2011.07.020_bib0055","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1212\/WNL.41.3.369","article-title":"Clozapine-related seizures","volume":"41","author":"Devinksy","year":"1991","journal-title":"Neurology"},{"key":"10.1016\/j.eplepsyres.2011.07.020_bib0060","doi-asserted-by":"crossref","first-page":"281","DOI":"10.2165\/00003495-199753020-00007","article-title":"Olanzapine, a review of its pharmacological properties and therapeutic efficacy in the management of schizophrenia and related psychoses","volume":"53","author":"Fulton","year":"1997","journal-title":"Drugs"},{"key":"10.1016\/j.eplepsyres.2011.07.020_bib0065","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1212\/WNL.36.9.1226","article-title":"Seizures and myoclonus in patients with Alzheimer's disease","volume":"36","author":"Hauser","year":"1986","journal-title":"Neurology"},{"key":"10.1016\/j.eplepsyres.2011.07.020_bib0070","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1002\/mds.22286","article-title":"Pregabalin- and gabapentin-associated myoclonus in a patient with chronic renal failure","volume":"24","author":"Healy","year":"2009","journal-title":"Mov. Disord."},{"key":"10.1016\/j.eplepsyres.2011.07.020_bib0075","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1345\/aph.1A207","article-title":"New-onset seizure associated with quetiapine and olanzapine","volume":"36","author":"Hedges","year":"2002","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.eplepsyres.2011.07.020_bib0080","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1007\/s00415-005-0970-1","article-title":"Gabapentin-induced severe myoclonus in a patient with impaired renal function","volume":"253","author":"Holtkamp","year":"2006","journal-title":"J. Neurol."},{"issue":"Suppl. 2","key":"10.1016\/j.eplepsyres.2011.07.020_bib0085","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1046\/j.1528-1157.2002.043s2019.x","article-title":"Antipsychotic drugs and epilepsy: indications and treatment guidelines","volume":"43","author":"Koch-Stoecker","year":"2002","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2011.07.020_bib0090","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1345\/aph.17385","article-title":"Seizure associated with olanzapine","volume":"33","author":"Lee","year":"1999","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.eplepsyres.2011.07.020_bib0095","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0013-4694(94)90070-1","article-title":"Spectrum of EEG abnormalities during clozapine treatment","volume":"91","author":"Malow","year":"1994","journal-title":"Electroencephalogr. Clin. Neurophysiol."},{"key":"10.1016\/j.eplepsyres.2011.07.020_bib0100","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1111\/j.1528-1157.1996.tb00537.x","article-title":"Movement disorders associated with the use of gabapentin","volume":"37","author":"Reeves","year":"1996","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2011.07.020_bib0105","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1191\/0269216303Pm772cr","article-title":"Myoclonic jerks associated with gabapentin","volume":"17","author":"Scullin","year":"2003","journal-title":"Palliat. Med."},{"key":"10.1016\/j.eplepsyres.2011.07.020_bib0110","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0920-1211(96)00061-7","article-title":"Kindling with clozapine: behavioral and molecular consequences","volume":"26","author":"Stevens","year":"1996","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2011.07.020_bib0115","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1001\/archpsyc.57.10.968","article-title":"Olanzapine treatment of psychotic and behavioral symptoms in patients with Alzheimer Disease in nursing care facilities: a double-blind, randomized, placebo-controlled trial","volume":"57","author":"Street","year":"2000","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.eplepsyres.2011.07.020_bib0120","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1192\/bjp.178.1.85-a","article-title":"Lowered seizure threshold on olanzapine","volume":"178","author":"Woolley","year":"2001","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.eplepsyres.2011.07.020_bib0125","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1345\/aph.18399","article-title":"Fatal status epilepticus associated with olanzapine therapy","volume":"33","author":"Wyderski","year":"1999","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.eplepsyres.2011.07.020_bib0130","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/j.0013-9580.2005.20804.x","article-title":"Gabapentin-induced myoclonus in end-stage renal disease","volume":"46","author":"Zhang","year":"2005","journal-title":"Epilepsia"}],"container-title":["Epilepsy Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121111002233?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121111002233?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T13:26:05Z","timestamp":1760275565000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920121111002233"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":26,"journal-issue":{"issue":"2-3","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["S0920121111002233"],"URL":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2011.07.020","relation":{},"ISSN":["0920-1211"],"issn-type":[{"value":"0920-1211","type":"print"}],"subject":[],"published":{"date-parts":[[2012,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Olanzapine-associated myoclonus","name":"articletitle","label":"Article Title"},{"value":"Epilepsy Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2011.07.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}